Skip to main content
17623 Suchergebnisse für:

Low Molecular Weight Heparin 

sortieren nach |
"Aktualität" sortiert die Ergebnisse nach Publikationsdatum. "Relevanz" berücksichtigt auch noch andere Faktoren wie zum Beispiel die Häufigkeit der Suchbegriffe im Text.
  1. 01.03.2024 | News

    Heparin/unspecified low-molecular-weight-heparin

    Lack of efficacy
  2. Open Access 01.12.2024 | OriginalPaper

    Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a randomized, placebo-controlled trial

    An increasing number of patients are prescribed single antiplatelet therapy for the prevention of myocardial infarction (MI) and coronary stent thrombosis more than 12 months after the placement of bare metal stents (BMSs) and drug-eluting stents …

  3. Open Access 01.12.2024 | OriginalPaper

    Efficacy of 5-fluorouracil (5-FU) and low molecular weight heparin (LMWH) in high-risk pediatric retinal detachment; randomized clinical trial

    Pediatric rhegmatogenous retinal detachments (PRRDs) are complex, rare occurrences and are often related to trauma, congenital abnormalities, genetic syndromes, high myopia, and prior ocular surgery. This is in contrast to the most common causes …

  4. Open Access 01.12.2024 | OriginalPaper

    Aspirin is as effective as low molecular weight heparins in preventing symptomatic venous thromboembolism following arthroscopic anterior cruciate ligament reconstruction

    Arthroscopic anterior cruciate ligament reconstruction (ACLR) is one of the most common orthopedic operations performed worldwide. In recent years, there has been an increase in the number of patients undergoing this surgery, particularly among …

  5. Open Access 01.12.2024 | ReviewPaper

    Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis

    Venous thromboembolic events (VTEs), including deep vein thrombosis (DVT) and pulmonary embolism (PE), remain major causes of morbidity and mortality in patients with cancer [ 1 ]. Patients with cancer increased sevenfold risk of venous thrombosis …

  6. Open Access 01.12.2024 | OriginalPaper

    Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis

    Preeclampsia (PE) is defined as new onset hypertension present after 20 weeks of gestation combined with proteinuria (> 300 mg/day) or other maternal organ dysfunction, such as renal insufficiency, liver involvement, neurological or hematological …

  7. 01.12.2023 | News

    Low-molecular-weight-heparins/warfarin

    Lack of efficacy: case report
  8. 24.01.2024 | ReviewPaper

    Direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: a systematic review and meta-analysis

  9. Open Access 01.12.2024 | OriginalPaper

    A randomized, controlled clinical study of low-molecular-weight heparin improving pregnancy outcomes in PCOS women undergoing IVF: study protocol

    Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age, characterized by androgen hyperplasia, anovulation, and polycystic ovary, with an incidence of 9–18% during reproductive-aged women [ 1 , 2 …]. In addition to the mechanism of ovulation disorder, PCOS patients also have the problem of poor endometrial receptivity. Regardless of natural or assisted conception, early pregnancy loss is pervasively among PCOS patients, 3–8 times higher than that of non-PCOS [

  10. 04.10.2023 | OriginalPaper

    Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials

    Coronavirus disease 2019 (COVID-19) carries a high risk of vascular thrombosis. However, whether a specific anticoagulation intensity strategy may prevent clinical worsening in severe COVID-19 patients is still debated. We conducted a joint …

  11. 22.11.2023 | Online First

    Distal Flap Heparinisation Versus Systemic Bolus of Low Molecular Weight Heparin for the Prevention of Vascular Congestion in Microvascular Free Flaps: A Randomised Clinical Trial

    Microvascular free flap surgery has been proven to be the most advanced and appropriate treatment strategy for most of the maxillofacial defects, especially the defects due to oral cancer. The literature has shown several improvements and …

  12. 31.05.2023 | OriginalPaper

    The effects of three different low-molecular-weight heparins on blood loss after intramedullary nailing of trochanteric fractures

    Proximal femur fractures have become of intense interest globally due to high cost of care and postoperative mortality rate. There has been no significant improvement in mortality or functional recovery over the past 50 years of surgical treatment …

  13. 01.07.2023 | News

    Aspirin/unspecified low molecular weight heparins

    Mallory Weiss syndrome: case report
  14. Open Access 01.12.2023 | OriginalPaper

    Comparison of the efficacy of low-molecular-weight heparin and fondaparinux sodium after total knee arthroplasty: a retrospective cohort study

    Knee osteoarthritis (KOA) is a common clinical joint disease that mainly develops in the elderly. It is a chronic degenerative disease with a high incidence of disability and deformity. The affected patients experience continuous knee swelling and …

  15. 08.07.2023 | OriginalPaper

    Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies

    Low-molecular-weight heparins (LMWHs) have historically served as the standard of care for the treatment of cancer-associated venous thromboembolism (CA-VTE). However, direct oral anticoagulants (DOACs) have emerged as another first-line treatment …

  16. Open Access 03.07.2023 | OriginalPaper

    Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration

    Low-molecular-weight heparin (LMWH) is an anticoagulant used to prevent clotting during blood purification treatments. This study aimed to evaluate the clinical use of the anti-factor Xa level (anti-Xa) for monitoring LMWH anticoagulant levels …

  17. 01.05.2023 | News

    Low molecular weight heparins/urokinase

    Bullous haemorrhagic dermatosis : case report
  18. Open Access 01.12.2023 | OriginalPaper

    Effect of low-molecular-weight heparin in women undergoing frozen-thawed embryo transfer cycles: a retrospective cohort study

    For those infertility couple, in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) is one of the most effective and successful assisted reproductive technologies (ARTs). Infertility affects approximately 15% of couples, and …

  19. 01.09.2022 | COVID-19 | OriginalPaper

    Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials

    Severe coronavirus disease 2019 (Covid-19) caused by SARS-CoV-2 causes hypercoagulability and increases the risk of thromboembolic disease [ 1 , 2 ].

  20. Open Access 01.12.2023 | OriginalPaper

    Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism

    Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), was globally the third most frequent acute cardiovascular syndrome and the second leading cause of mortality in individuals with cancers [ 1 ]. The …

Suchergebnisse filtern:

Suchoperatoren:

„ ... ... “ Findet Dokumente mit genau dieser Wortgruppe in exakt dieser Schreibweise und Reihenfolge (z.B., "rheumatische Beschwerden").
AND / UND Findet Dokumente, in denen beide Begriffe zusammen vorkommen (z.B., alkohol UND demenz).
OR / ODER Findet Dokumente, in denen einer der beiden oder beide Begriffe vorkommen (z.B., hiv ODER aids).
Leerzeichen Findet Dokumente, in denen alle Begriffe vorkommen. Der Leerschritt wird als UND interpretiert (z.B., isolierte systolische hypertonie).
NOT / NICHT Findet Dokumente, in denen der Begriff nach NOT nicht vorkommt (z.B., sars NOT sars-cov-2).
COUNT(...)>n Findet Dokumente, in denen der gesuchte Begriff mehr als n mal vorkommt. n steht für eine beliebige Anzahl (z.B., COUNT(mammakarzinom)>8).
NEAR(..., ..., ) Findet Dokumente, in denen beide Begriffe in beliebiger Reihenfolge innerhalb von maximal n Worten zueinander stehen. Empfehlung: wählen Sie zwischen 15 und 30 als maximale Wortanzahl (z.B., NEAR(covid, diabetes,20)).
* Findet Dokumente, in denen der Begriff in Wortvarianten vorkommt, wobei diese VOR, HINTER oder VOR und HINTER dem Suchbegriff anschließen können (z.B., thrombose*, *thrombose, *thrombose*).
? Findet Dokumente mit dem Suchbegriff in verschiedenen Schreibweisen, hier mit s oder z, also organisation und organization. Das ? steht für eine einzige Stelle (z.B., organi?ation).
& + - Sonderzeichen werden als UND interpretiert (z.B., Diagnose + Therapie).

Sie können Operatoren mit Ihrer Suchanfrage kombinieren, um diese noch präziser einzugrenzen.

Fahren Sie mit der Maus über den Suchoperator, um eine Erklärung seiner Funktionsweise anzuzeigen.